Mingyang Ma

Title: Innovations of Mingyang Ma in Insulin Secretion and Islet Viability

Introduction

Mingyang Ma is an accomplished inventor based in Charlottesville, VA (US). He has made significant contributions to the field of biomedical research, particularly in the area of insulin secretion and pancreatic islet viability. His innovative work has the potential to impact the treatment of diabetes and related conditions.

Latest Patents

Mingyang Ma holds a patent titled "Compositions and methods for promoting islet viability and enhancing insulin secretion." This patent encompasses various compositions and methods aimed at regenerating pancreatic islet viability and enhancing insulin secretion in vitro, ex vivo, and in vivo. The patent also addresses the prevention of rejection of transplanted islets and offers solutions for treating conditions associated with abnormal insulin responsiveness to glucose. The compositions may include peptides or pharmaceutically acceptable salts, with specific amino acid sequences outlined in the patent.

Career Highlights

Mingyang Ma is associated with the University of Virginia Patent Foundation, where he continues to advance his research and innovations. His work is characterized by a commitment to improving health outcomes through scientific discovery and application.

Collaborations

Mingyang Ma has collaborated with notable colleagues, including Gordon W Laurie and Kenneth Brayman. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking research and innovation.

Conclusion

Mingyang Ma's contributions to the field of insulin secretion and islet viability exemplify the impact of innovative research on healthcare. His patent and ongoing work at the University of Virginia Patent Foundation highlight the importance of scientific advancements in addressing critical health challenges.